Clinical Trials in Nashville

Showing 6561-6580 of 20,298 trials

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152) as monotherapy or in combination in patients with solid tumors and aggressive non-hodgkin's lymphoma (NHL).

Neoplasms

Vincerx Pharma, Inc.110 participantsStarted Feb 2016

Springdale, Arkansas, United States • Louisville, Kentucky, United States • Silver Spring, Maryland, United States +13 more locations

RECRUITINGPhase 1< 1 mile

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

NCT06034275

Dose Escalation - Determine the maximum tolerated dose (MTD), if possible, or minimum optimal biologic dose (OBD), and evaluate the safety and tolerability of VIP943 in subjects with advanced CD123+ hematologic malignancies

Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaHigh-risk Myelodysplastic Syndrome

Vincerx Pharma, Inc.36 participantsStarted Sep 2023

Birmingham, Alabama, United States • Cincinnati, Ohio, United States • Nashville, Tennessee, United States +2 more locations

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Find Trials by Condition in Nashville

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Expanding Rural Health Cancer Control Capacity

Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)

Social Needs App for Oncology Patients Phase II

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Pediatric Adenotonsillectomy Trial for Snoring

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

Zip-Stitch® in Minimally-Invasive Surgery (ZIMS) - Safety & Efficacy in Hysterectomy

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers